ReviewCureus2025
Systematic Review of Clinical and Imaging Features for Differentiating Pulmonary Tuberculosis and Nontuberculous Mycobacterial Pulmonary Diseases.
Review in Cureus, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Pulmonary tuberculosis (TB) and nontuberculous mycobacterial pulmonary disease (NTM-PD) often present with similar clinical and radiological features, making accurate differentiation essential. This systematic review aimed to summarize diagnostic features that distinguish pulmonary TB from NTM-PD. A systematic review following Preferred Reporting Items for Systematic Reviews and Meta-Analyses guidelines searched PubMed for studies differentiating pulmonary TB from NTM-PD. Eligible studies were screened by pulmonary disease specialists, and data on study design, demographics, and diagnostic factors were extracted. Risk of bias was assessed using the Quality Assessment of Diagnostic Accuracy Studies-2 tool, and meta-analysis with random-effects models evaluated effect sizes and heterogeneity. A PubMed search identified 847 studies, of which 11 observational studies met the inclusion criteria. Imaging findings were the most commonly distinguishing features, with the absence of bronchiectasis more frequently observed in pulmonary TB. Meta-analysis showed a significant association between the absence of bronchiectasis and TB diagnosis (odds ratio (OR): 0.19; 95% CI: 0.10-0.36; I² = 82%). Three studies also reported that positive interferon-gamma release assay (IGRA) results were significantly associated with pulmonary TB (OR: 17.34; 95% CI: 6.71-44.75; I² = 68%). In addition, pulmonary TB was more frequently associated with upper lobe opacities and less involvement of the right middle lobe than NTM-PD. These findings reveal that radiological patterns and the IGRA results may serve as useful markers for differentiating pulmonary TB and NTM-PD. Further large-scale studies are required to validate these findings.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.